Saturday, July 11, 2026

APEC 2025: What Will Trump’s and Xi’s Visits Mean for South Korea’s Practical Diplomacy?

The APEC summit in Gyeongju tests South Korea's pragmatic diplomacy amid U.S.-China tensions, with key meetings scheduled.

How Hudson AI and Sinclair are Revolutionizing K-Content in the U.S. with Next-Gen AI Dubbing

Hudson AI partners with Sinclair Broadcast Group to launch a K-content channel in the U.S. using advanced AI dubbing technology.

Two Stocks That Are Promising and the Safest According to Specialists

The latest buzz on Wall Street is...

Tag: Truxima

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Celltrion’s Truxima becomes first rituximab biosimilar in U.S. to receive interchangeability designation

Celltrion's Truxima gains FDA interchangeability status, enhancing its market position and credibility in blood cancer treatment.

Truxima: How the First Korean Biosimilar Achieved 35.8% Market Share in the U.S.!

Celltrion’s Truxima becomes South Korea's first biosimilar to lead U.S. prescription market, boosted by tariff exemptions and strong growth.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.